Histone Demethylation A Novel Mechanism in Hormone-Mediated Gene Regulation

组蛋白去甲基化是激素介导的基因调控的新机制

基本信息

  • 批准号:
    7467859
  • 负责人:
  • 金额:
    $ 37.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-20 至 2011-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Histone modifications provide a mechanism for regulating the diverse structural and functional features of chromatin, including control of gene regulation and maintenance of genomic integrity. Histone modifications play important roles in cell growth and survival, differentiation, embryonic development, and their related pathologies, including oncogenic transformation. Recently, we have made the exciting discovery of the first bona fide histone demethylase LSD1 (Lysine-Specific Demethylase 1). The identification of LSD1 as an H3-lysine 4 (H3-K4) specific histone demethylase revealed the reversible nature of histone methylation. It not only settled the longstanding debate regarding histone demethylation, but also represented a major advance in our understanding of epigenetic gene regulation. LSD1 has also been found in a variety of multi-subunit complexes involved in gene regulation. It is a coregulator for androgen receptor mediated gene regulation, suggesting that histone demethylation may serve as a fundamental mechanism for hormone action at the transcription level. The focus of our research is on the regulation of histone demethylase(s) and the biological consequences of histone demethylation in nuclear receptor mediated gene regulation. These are fundamental events in hormone-dependent biological processes and are important for stem cell differentiation and embryonic development. Using LSD1 as the first molecular model, we aim to define histone demethylation as a novel, yet widespread regulatory mechanism for steroid hormone receptor (e.g. androgen, glucocorticoid, and thyroid receptors) action on target genes. Data derived from these studies will contribute to the rapidly advancing and groundbreaking field of epigenetics. The findings from these studies will provide significant insights into the mechanisms underlying histone demethylation as it relates to nuclear hormone receptor mediated gene regulation. They will also greatly contribute to our understanding of hormone physiology and a variety of human pathologies, including tumorigenesis and developmental anomalies.Histone modifications provide a mechanism for regulating the diverse structural and functional features of chromatin, including control of gene regulation and maintenance of genomic integrity. Histone modifications play important roles in cell growth and survival, differentiation, embryonic development, and their related pathologies, including oncogenic transformation. The focus of our research is on the regulation of histone demethylase(s) and the biological consequences of histone demethylation in nuclear receptor mediated gene regulation. These are fundamental events in hormone-dependent biological processes and are important for stem cell differentiation and embryonic development.
描述(由申请人提供):组蛋白修饰提供了一种调节染色质不同结构和功能特征的机制,包括控制基因调控和维持基因组完整性。组蛋白修饰在细胞生长和存活、分化、胚胎发育及其相关病理学(包括致癌转化)中起重要作用。最近,我们发现了第一个真正的组蛋白去甲基化酶LSD 1(赖氨酸特异性去甲基化酶1)。LSD 1作为H3-赖氨酸4(H3-K4)特异性组蛋白去甲基化酶的鉴定揭示了组蛋白甲基化的可逆性质。它不仅解决了关于组蛋白去甲基化的长期争论,而且代表了我们对表观遗传基因调控的理解的重大进展。LSD 1也被发现存在于多种参与基因调控的多亚基复合物中。它是雄激素受体介导的基因调控的辅助调节因子,这表明组蛋白去甲基化可能是转录水平上激素作用的基本机制。 我们的研究重点是组蛋白去甲基化酶的调控以及组蛋白去甲基化在核受体介导的基因调控中的生物学后果。这些都是依赖于胚胎干细胞的生物学过程中的基本事件,对干细胞分化和胚胎发育很重要。使用LSD 1作为第一个分子模型,我们的目标是将组蛋白去甲基化定义为类固醇激素受体(例如雄激素,糖皮质激素和甲状腺受体)对靶基因作用的一种新的,但广泛的调节机制。从这些研究中获得的数据将有助于表观遗传学的快速发展和突破性领域。这些研究的发现将为深入了解组蛋白去甲基化的机制提供重要见解,因为它与核激素受体介导的基因调控有关。它们也将极大地有助于我们了解激素生理学和各种人类病理学,包括肿瘤发生和发育异常。组蛋白修饰提供了一种调节染色质不同结构和功能特征的机制,包括控制基因调控和维持基因组完整性。组蛋白修饰在细胞生长和存活、分化、胚胎发育及其相关病理学(包括致癌转化)中起重要作用。 我们的研究重点是组蛋白去甲基化酶的调控以及组蛋白去甲基化在核受体介导的基因调控中的生物学后果。这些都是依赖于胚胎干细胞的生物学过程中的基本事件,对干细胞分化和胚胎发育很重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yujiang Geno Shi其他文献

Structural insight into substrate recognition by histone demethylase LSD2/KDM1b
  • DOI:
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
  • 作者:
    Zhenghong Dong;Jian Fang;Ping Wang;Tingting Zhu;Wei Gong;Rui Fang;Yujiang Geno Shi;Ze Li;Yanhui Xu;
  • 通讯作者:
TET2 promotes anti-tumor immunity by governing G-MDSCs andCD8(+)T-cell numbers
  • DOI:
    10 -->:10.15252/embr.201949425文章关键词:Anti‐tumor immune response,Granulocytic myeloid‐derived suppr
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
  • 作者:
    Shuangqi Li;Jiuxing Feng;Feizhen Wu;Jiabing Cai;Xinyu Zhang;Haikun Wang;Irfete S Fetahu;Isabella Iwanicki;Dingailu Ma;Tao Hu;Hang Liu;Bingjie Wang;Guoming Shi;Li Tan;Yujiang Geno Shi
  • 通讯作者:
    Yujiang Geno Shi
SPT6 regulates H3K14Ac deposition in mouse embryonic stem cells
SPT6调节小鼠胚胎干细胞中H3K14Ac的沉积
  • DOI:
    10.1016/j.celrep.2025.115757
  • 发表时间:
    2025-06-24
  • 期刊:
  • 影响因子:
    6.900
  • 作者:
    Daixuan Zhang;Li Dong;Ying Cai;Peng Zhao;Qingqing Cai;Jian Zhang;Yajun Hu;Mandi Mu;Siyi Cheng;Jin Wang;Min Zeng;Chenxi He;Lei Zhang;Hui Yang;Fei Xavier Chen;Li Tan;Feizhen Wu;Yujiang Geno Shi;Wenqi Xu;Hongjie Shen
  • 通讯作者:
    Hongjie Shen
A tango between NSUN2 and TET2: defining both the fate and origin of RNA
  • DOI:
    10.1007/s11427-024-2862-x
  • 发表时间:
    2025-03-12
  • 期刊:
  • 影响因子:
    9.500
  • 作者:
    Tianbao Shang;Lu Liu;Zitan Li;Yichi Xu;Yujiang Geno Shi;Li Tan
  • 通讯作者:
    Li Tan
Binding to m6A RNA promotes YTHDF2-mediated phase separation
  • DOI:
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
  • 作者:
    Jiahua Wang;Liyong Wang;Jianbo Diao;Yujiang Geno Shi;Yang Shi;Honghui Ma;Hongjie Shen
  • 通讯作者:
    Hongjie Shen

Yujiang Geno Shi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yujiang Geno Shi', 18)}}的其他基金

De-Regulation of 5hmC/TET2 Tumor Suppressor under Anti-Estrogen Therapy
抗雌激素治疗下 5hmC/TET2 肿瘤抑制因子的失调
  • 批准号:
    9250733
  • 财政年份:
    2016
  • 资助金额:
    $ 37.32万
  • 项目类别:
Post Translational Regulation of TET2 Function by Glucose Signaling
葡萄糖信号转导对 TET2 功能的翻译后调节
  • 批准号:
    9100886
  • 财政年份:
    2015
  • 资助金额:
    $ 37.32万
  • 项目类别:
Histone Demethylases and Their Regulation
组蛋白去甲基化酶及其调控
  • 批准号:
    7894532
  • 财政年份:
    2006
  • 资助金额:
    $ 37.32万
  • 项目类别:
Histone Demethylases and Their Regulation
组蛋白去甲基化酶及其调控
  • 批准号:
    7661564
  • 财政年份:
    2006
  • 资助金额:
    $ 37.32万
  • 项目类别:
Histone Demethylases and Their Regulation
组蛋白去甲基化酶及其调控
  • 批准号:
    8297242
  • 财政年份:
    2006
  • 资助金额:
    $ 37.32万
  • 项目类别:
Histone Demethylases and Their Regulation
组蛋白去甲基化酶及其调控
  • 批准号:
    7478166
  • 财政年份:
    2006
  • 资助金额:
    $ 37.32万
  • 项目类别:
Histone Demethylases and Their Regulation
组蛋白去甲基化酶及其调控
  • 批准号:
    7268786
  • 财政年份:
    2006
  • 资助金额:
    $ 37.32万
  • 项目类别:
Histone Demethylases and Their Regulation
组蛋白去甲基化酶及其调控
  • 批准号:
    7132876
  • 财政年份:
    2006
  • 资助金额:
    $ 37.32万
  • 项目类别:
Roles of CtBP in cancer and its mechanism of action
CtBP在癌症中的作用及其作用机制
  • 批准号:
    6784605
  • 财政年份:
    2003
  • 资助金额:
    $ 37.32万
  • 项目类别:
Roles of CtBP in cancer and its mechanism of action
CtBP在癌症中的作用及其作用机制
  • 批准号:
    6649016
  • 财政年份:
    2003
  • 资助金额:
    $ 37.32万
  • 项目类别:

相似海外基金

Abnormalities in androgens and ovarian markers in reproductive-age racially and ethnically diverse women in a prospective longitudinal cohort
前瞻性纵向队列中不同种族和民族的育龄女性雄激素和卵巢标志物的异常
  • 批准号:
    10930196
  • 财政年份:
    2023
  • 资助金额:
    $ 37.32万
  • 项目类别:
Nonalcoholic Fatty Liver Disease (NAFLD) in Polycystic Ovary Syndrome: The Role of Androgens on Liver Injury and NAFLD Progression
多囊卵巢综合征中的非酒精性脂肪肝 (NAFLD):雄激素在肝损伤和 NAFLD 进展中的作用
  • 批准号:
    10735807
  • 财政年份:
    2023
  • 资助金额:
    $ 37.32万
  • 项目类别:
Elucidation of the mechanisms by which cells recognize and respond to different levels of androgens
阐明细胞识别和响应不同水平雄激素的机制
  • 批准号:
    10418461
  • 财政年份:
    2022
  • 资助金额:
    $ 37.32万
  • 项目类别:
Sexual Differentiation of the Brain and Behaviour: Central and Peripheral Targets of Androgens
大脑和行为的性别分化:雄激素的中枢和外周目标
  • 批准号:
    RGPIN-2019-04999
  • 财政年份:
    2022
  • 资助金额:
    $ 37.32万
  • 项目类别:
    Discovery Grants Program - Individual
Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD
雄激素对患有 NAFLD 的年轻女性组织特异性脂质代谢和肝损伤的影响
  • 批准号:
    10570208
  • 财政年份:
    2022
  • 资助金额:
    $ 37.32万
  • 项目类别:
Paxillin and Androgens in the Regulation of Ovarian Follicle Development
桩蛋白和雄激素在卵巢卵泡发育调节中的作用
  • 批准号:
    10688086
  • 财政年份:
    2022
  • 资助金额:
    $ 37.32万
  • 项目类别:
Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD
雄激素对患有 NAFLD 的年轻女性组织特异性脂质代谢和肝损伤的影响
  • 批准号:
    10355174
  • 财政年份:
    2022
  • 资助金额:
    $ 37.32万
  • 项目类别:
Defining the impact of androgens on uterine immune cell function during endometrial tissue repair
确定子宫内膜组织修复过程中雄激素对子宫免疫细胞功能的影响
  • 批准号:
    2744296
  • 财政年份:
    2022
  • 资助金额:
    $ 37.32万
  • 项目类别:
    Studentship
Use of novel 11-oxygenated androgens to improve diagnostic accuracy and therapeutics in polycystic ovary syndrome
使用新型 11-含氧雄激素提高多囊卵巢综合征的诊断准确性和治疗效果
  • 批准号:
    10431620
  • 财政年份:
    2022
  • 资助金额:
    $ 37.32万
  • 项目类别:
Paxillin and Androgens in the Regulation of Ovarian Follicle Development
桩蛋白和雄激素在卵巢卵泡发育调节中的作用
  • 批准号:
    10525097
  • 财政年份:
    2022
  • 资助金额:
    $ 37.32万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了